Adaptive Biotechnologies (ADPT) Income from Non-Controlling Interests (2021 - 2026)
Adaptive Biotechnologies (ADPT) posted Income from Non-Controlling Interests of $18000.0 for Q1 2026, up 1900.0% sequentially from -$1000.0 in Q3 2025, and down 18.18% YoY from $22000.0 in Q1 2025.
Adaptive Biotechnologies (ADPT) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 6 years of Income from Non-Controlling Interests data on file, last reported at $18000.0 in Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 18.18% year-over-year to $18000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38000.0 (up 169.09% YoY) and the FY2025 annual result came in at $42000.0, up 140.78% from the prior year.
- Income from Non-Controlling Interests improved to $18000.0 in Q1 2026 per ADPT's latest filing, from -$1000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $22000.0 in Q1 2025, with the low at -$60000.0 in Q1 2022.
- Average Income from Non-Controlling Interests over 5 years is -$17125.0, with a median of -$26000.0 recorded in 2023.
- Year-over-year, Income from Non-Controlling Interests sank 2500.0% in 2024 and surged 184.62% in 2025.
- Adaptive Biotechnologies' Income from Non-Controlling Interests stood at -$41000.0 in 2022, then jumped by 36.59% to -$26000.0 in 2023, then climbed by 3.85% to -$25000.0 in 2024, then surged by 96.0% to -$1000.0 in 2025, then surged by 1900.0% to $18000.0 in 2026.
- Business Quant data shows ADPT's Income from Non-Controlling Interests at $18000.0 in Q1 2026, -$1000.0 in Q3 2025, and $21000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 1.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | -25,000.00 |
| Sep 30, 2024 | -26,000.00 |
| Jun 30, 2024 | -26,000.00 |
| Mar 31, 2024 | -26,000.00 |
| Dec 31, 2023 | -26,000.00 |
| Sep 30, 2023 | -26,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -41,000.00 |
| Sep 30, 2022 | -38,000.00 |
| Jun 30, 2022 | -38,000.00 |
| Mar 31, 2022 | -60,000.00 |
| Dec 31, 2021 | 76,000.00 |
| Sep 30, 2021 | -95,000.00 |